Capecitabine in Breast Cancer: Current Status
- 1 January 2001
- journal article
- review article
- Published by Elsevier in Clinical Breast Cancer
- Vol. 1 (4) , 288-293
- https://doi.org/10.3816/cbc.2001.n.003
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Preferential activation of capecitabine in tumor following oral administration to colorectal cancer patientsCancer Chemotherapy and Pharmacology, 2000
- Chemotherapy of breast cancer: are the taxanes going to change the natural history of breast cancer?Expert Opinion on Pharmacotherapy, 2000
- Cytotoxic and hormonal treatment for metastatic breast cancer: a systematic review of published randomized trials involving 31,510 women.Journal of Clinical Oncology, 1998
- Phase I and pharmacologic study of intermittent twice-daily oral therapy with capecitabine in patients with advanced and/or metastatic cancer.Journal of Clinical Oncology, 1998
- Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancerBritish Journal of Cancer, 1998
- Continuous 5-fluorouracil in the treatment of breast cancerBritish Journal of Cancer, 1994
- 5-Fluorouracil Plus Leucovorin in Women with Metastatic Breast Cancer A Phase II StudyAmerican Journal of Clinical Oncology, 1991
- Fluorouracil and high-dose leucovorin in previously treated patients with metastatic breast cancer.Journal of Clinical Oncology, 1989
- 5-fluorouracil with leucovorin in breast cancerCancer, 1989
- Protracted ambulatory venous infusion of 5-fluorouracilAmerican Journal of Clinical Oncology, 1983